A006 DPI

DRUG2 trials

Sponsors

Amphastar Pharmaceuticals, Inc.

Conditions

Asthma

Phase 2

Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation

CompletedNCT02210806

Amphastar Pharmaceuticals, Inc.Asthma

Start: 2014-07-31End: 2014-10-31Updated: 2017-04-19

Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers

CompletedNCT02271334

Amphastar Pharmaceuticals, Inc.Asthma

Start: 2014-08-31End: 2015-03-31Updated: 2017-04-19